---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-055075"
form_type: "8-K"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2022-09-09T23:59:59+00:00"
generated_at: "2026-06-23T11:45:38.236019+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma appoints Leeds Chow as CFO and Principal Accounting Officer effective Sept 4, 2022

## Summary
- Leeds Chow, 34, previously Controller since March 2021, appointed CFO and Principal Accounting Officer on Sept 4, 2022.
- Mr. Chow has over 12 years experience in audit and financing, including family office and Hong Kong IPO advisory roles.
- He holds a BA in Business Economics with Accounting Emphasis from the University of California, Santa Barbara.
- No departure of prior CFO was announced; the board determined the reappointment to be in the Company's best interests.

## SEC filing metadata
- accession: 0001213900-22-055075
- form_type: 8-K
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2022-09-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390022055075/0001213900-22-055075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390022055075/ea165554-8k_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-055075
- JSON: https://secwatch.observer/filing/0001213900-22-055075.json
- Plain text: https://secwatch.observer/filing/0001213900-22-055075.txt

## Key facts
- Executive change
  Leeds Chow was appointed as Chief Financial Officer and Principal Accounting Officer at ABVC BIOPHARMA, INC..
  - Action: appointed
  - Role: Chief Financial Officer and Principal Accounting Officer
  source text: the Board has determined that it is in the best interests of ABVC BIOPHARMA, INC. (the “ Company ”) to reappoint Leeds Chow, age 34, the Company’s Controller, as Chief Financial Officer and Principal Accounting Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173313/000121390022055075/0001213900-22-055075-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.